Insight

Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute

Photo from Brandon Huffman/X

Feb 19, 2024, 09:20

Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute

Brandon Huffman, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, shared an X post by James Cleary, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, adding:

“Congratulations to Harsh Singh, James Cleary, and the team on a very well-done description of the unique entity – HER2 (ERBB2) amplified CRC! Exciting translational work happening at Dana-Farber Cancer Institute!”

Quoting James Cleary’s post:

“In this collaboration with Harsh Singh, Lab Sethi, Jason Hornick we examined mechanisms of resistance and sensitivity to targeted therapy in HER2 amplified colorectal cancer.”

Proceed to the article.
Source: Brandon Huffman/X and James Cleary/X

Brandon Huffman cancer colorectal cancer Dana-Farber Cancer Institute Dana-Farber Gastrointestinal Cancer Center Dana-Farber's Young-Onset Colorectal Cancer Center Harsh Singh HER2 amplified colorectal cancer James Cleary Jason Hornick Lab Sethi OncoDaily Oncology

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage